SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-055043
Filing Date
2012-08-07
Accepted
2012-08-07 11:18:14
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-12810_110q.htm 10-Q 1460624
2 EX-31.1 a12-12810_1ex31d1.htm EX-31.1 11596
3 EX-31.2 a12-12810_1ex31d2.htm EX-31.2 12019
4 EX-32.1 a12-12810_1ex32d1.htm EX-32.1 6067
5 EX-32.2 a12-12810_1ex32d2.htm EX-32.2 6273
  Complete submission text file 0001104659-12-055043.txt   8664463

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amag-20120630.xml EX-101.INS 1389602
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amag-20120630.xsd EX-101.SCH 57613
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amag-20120630_cal.xml EX-101.CAL 54105
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT amag-20120630_lab.xml EX-101.LAB 859389
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amag-20120630_pre.xml EX-101.PRE 404367
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amag-20120630_def.xml EX-101.DEF 273267
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02421 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 121011898
SIC: 2834 Pharmaceutical Preparations